| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,237 |
19,501 |
$2.01M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,358 |
3,855 |
$857K |
| 99201 |
|
2,581 |
1,948 |
$331K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,822 |
1,010 |
$323K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,641 |
1,168 |
$298K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,668 |
1,489 |
$269K |
| 97750 |
|
1,902 |
1,052 |
$214K |
| 97139 |
|
2,870 |
926 |
$174K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,330 |
1,178 |
$158K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
490 |
490 |
$154K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,489 |
1,357 |
$117K |
| J3490 |
Unclassified drugs |
7,177 |
4,534 |
$108K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,389 |
1,325 |
$103K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,038 |
1,008 |
$88K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,033 |
947 |
$81K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
82 |
81 |
$60K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
153 |
143 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
818 |
788 |
$32K |
| 80053 |
Comprehensive metabolic panel |
3,190 |
2,922 |
$32K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
171 |
170 |
$32K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
579 |
566 |
$30K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,941 |
1,759 |
$29K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,991 |
1,854 |
$29K |
| 99070 |
|
1,924 |
1,062 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,402 |
3,088 |
$25K |
| 71046 |
Radiologic examination, chest; 2 views |
514 |
493 |
$25K |
| Q3014 |
Telehealth originating site facility fee |
309 |
287 |
$23K |
| 73562 |
|
262 |
249 |
$22K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
125 |
125 |
$19K |
| 76830 |
Ultrasound, transvaginal |
42 |
42 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
175 |
170 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
25 |
24 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
994 |
929 |
$10K |
| 83690 |
|
1,423 |
1,323 |
$9K |
| 73630 |
|
103 |
93 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
263 |
258 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
165 |
148 |
$7K |
| 84484 |
|
687 |
643 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
557 |
457 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
12 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
882 |
786 |
$6K |
| 81001 |
|
1,489 |
1,398 |
$6K |
| 73110 |
|
52 |
42 |
$5K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
283 |
269 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
60 |
58 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
325 |
275 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
344 |
315 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
381 |
370 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
396 |
385 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
15 |
14 |
$3K |
| 80305 |
|
261 |
252 |
$3K |
| Z7502 |
|
61 |
59 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
106 |
96 |
$2K |
| 73030 |
|
15 |
13 |
$1K |
| 0002A |
|
37 |
37 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36 |
34 |
$1K |
| 81003 |
|
367 |
354 |
$1K |
| 85730 |
|
218 |
213 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
149 |
145 |
$782.59 |
| 87088 |
|
82 |
78 |
$774.41 |
| 85610 |
|
232 |
225 |
$765.90 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
57 |
57 |
$749.44 |
| 90756 |
|
16 |
16 |
$719.36 |
| 0001A |
|
25 |
25 |
$625.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
40 |
40 |
$437.41 |
| 81025 |
|
132 |
128 |
$426.48 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
57 |
56 |
$383.90 |
| 0011A |
|
14 |
14 |
$350.00 |
| 83605 |
|
28 |
26 |
$286.75 |
| J2060 |
Injection, lorazepam, 2 mg |
30 |
26 |
$264.71 |
| J7050 |
Infusion, normal saline solution, 250 cc |
48 |
41 |
$248.26 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12 |
12 |
$165.24 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$150.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
268 |
265 |
$115.92 |
| 87186 |
|
12 |
12 |
$94.73 |
| 82962 |
|
13 |
13 |
$34.28 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
13 |
13 |
$0.00 |